Jason Bednar
Stock Analyst at Piper Sandler
(2.28)
# 2,706
Out of 5,132 analysts
199
Total ratings
42.57%
Success rate
-2.54%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Reiterates: Neutral | $205 → $170 | $175.89 | -3.35% | 13 | Feb 10, 2026 | |
| NVST Envista Holdings | Reiterates: Neutral | $21 → $25 | $28.97 | -13.70% | 15 | Feb 6, 2026 | |
| ALGN Align Technology | Maintains: Overweight | $200 → $220 | $186.77 | +17.79% | 33 | Feb 5, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $91 → $94 | $80.34 | +17.00% | 2 | Jan 30, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $44.55 | +12.23% | 1 | Jan 12, 2026 | |
| SHC Sotera Health Company | Upgrades: Overweight | $17 → $24 | $17.12 | +40.19% | 4 | Jan 9, 2026 | |
| COO The Cooper Companies | Reiterates: Overweight | $83 → $94 | $82.99 | +13.27% | 15 | Dec 5, 2025 | |
| ICUI ICU Medical | Maintains: Overweight | $153 → $172 | $144.86 | +18.74% | 3 | Nov 7, 2025 | |
| SOLV Solventum | Maintains: Overweight | $94 → $98 | $75.55 | +29.72% | 8 | Nov 7, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Overweight | $105 → $109 | $81.66 | +33.48% | 14 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $4 | $4.64 | -13.79% | 8 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $200 → $210 | $130.15 | +61.35% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $9 → $2.5 | $1.47 | +70.07% | 12 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $34 | $10.99 | +209.37% | 11 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $16 | $12.95 | +23.55% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $77 | $78.19 | -1.52% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $4.78 | -5.86% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $248.35 | +6.70% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $3.40 | +76.47% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $7.21 | -2.91% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $20 | $1.05 | +1,804.76% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $485.84 | -23.43% | 4 | Jan 3, 2024 |
Becton, Dickinson and Company
Feb 10, 2026
Reiterates: Neutral
Price Target: $205 → $170
Current: $175.89
Upside: -3.35%
Envista Holdings
Feb 6, 2026
Reiterates: Neutral
Price Target: $21 → $25
Current: $28.97
Upside: -13.70%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $200 → $220
Current: $186.77
Upside: +17.79%
GE HealthCare Technologies
Jan 30, 2026
Maintains: Overweight
Price Target: $91 → $94
Current: $80.34
Upside: +17.00%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $44.55
Upside: +12.23%
Sotera Health Company
Jan 9, 2026
Upgrades: Overweight
Price Target: $17 → $24
Current: $17.12
Upside: +40.19%
The Cooper Companies
Dec 5, 2025
Reiterates: Overweight
Price Target: $83 → $94
Current: $82.99
Upside: +13.27%
ICU Medical
Nov 7, 2025
Maintains: Overweight
Price Target: $153 → $172
Current: $144.86
Upside: +18.74%
Solventum
Nov 7, 2025
Maintains: Overweight
Price Target: $94 → $98
Current: $75.55
Upside: +29.72%
Merit Medical Systems
Oct 31, 2025
Reiterates: Overweight
Price Target: $105 → $109
Current: $81.66
Upside: +33.48%
Aug 7, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $4.64
Upside: -13.79%
Aug 6, 2025
Maintains: Overweight
Price Target: $200 → $210
Current: $130.15
Upside: +61.35%
Jul 31, 2025
Downgrades: Neutral
Price Target: $9 → $2.5
Current: $1.47
Upside: +70.07%
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $10.99
Upside: +209.37%
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $12.95
Upside: +23.55%
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $78.19
Upside: -1.52%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $4.78
Upside: -5.86%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $248.35
Upside: +6.70%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $3.40
Upside: +76.47%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $7.21
Upside: -2.91%
Aug 7, 2024
Maintains: Overweight
Price Target: $70 → $20
Current: $1.05
Upside: +1,804.76%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $485.84
Upside: -23.43%